Suppression of hepatic lymphokine-activated killer cell induction by murine Kupffer cells and hepatocytes.
Murine lymphokine-activated-killer cell activity was readily induced by culturing spleen cells with 10 U/ml of interleukin-2 for 4 days. In contrast, very little activity was generated under the same culture conditions when nonparenchymal liver cells were used as the responding cells. It was concluded that Kupffer cells produced prostaglandin and interferon alpha/beta, which suppressed lymphokine-activated-killer induction because (a) induction of lymphokine-activated-killer activity from nonparenchymal liver cells was observed in the presence of indomethacin and anti-interferon alpha/beta antibody; (b) when adherent nonparenchymal liver cells, primarily Kupffer cells, were removed, lymphokine-activated-killer activity could be obtained with interleukin-2 alone; (c) coculture of Kupffer cells with nonadherent nonparenchymal liver cells in a two-chambered system inhibited lymphokine-activated killer cell induction in a dose-dependent manner; (d) exogenous prostaglandin E2 and interferon alpha/beta added at the start of culture inhibited interleukin-2-induced cytotoxicity and proliferation, whereas the other major prostaglandin species in the liver, prostaglandin D2, had little effect. These findings are distinctive with Kupffer cells because splenic macrophages did not exert such inhibition in parallel experiments. Moreover, the supernatant collected from the 24-hr culture of nonparenchymal liver cells contained greater than 20-fold more prostaglandin E2 and interferon alpha/beta than that from culture of spleen cells. In subsequent in vivo experiments, when interleukin-2 was given intraperitoneally to mice, the combination of indomethacin and anti-interferon alpha/beta antibody significantly enhanced lymphokine-activated-killer activity recovered from the liver.(ABSTRACT TRUNCATED AT 250 WORDS)
Tzung
S P
SP
Department of Medicine, Veterans Administration Medical Center, Buffalo, NY.
Gaines
K C
KC
Lance
P
P
Ehrke
M J
MJ
Cohen
S A
SA
D000818:Animals; D002455:Cell Division; D015232:Dinoprostone / Q000096:biosynthesis / Q000502:physiology*; D015536:Down-Regulation; D005260:Female; D007213:Indomethacin / Q000494:pharmacology; D007370:Interferon Type I / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000502:physiology*; D015979:Killer Cells, Lymphokine-Activated / Q000166:cytology*; D007728:Kupffer Cells / Q000378:metabolism*; D008099:Liver / Q000166:cytology / Q000378:metabolism*; D051379:Mice; D008810:Mice, Inbred C57BL; D015230:Prostaglandin D2 / Q000494:pharmacology
D007370:Interferon Type I; D015232:Dinoprostone; D015230:Prostaglandin D2; D007213:Indomethacin